A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion is a research paper published in JCI Insight (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), the S. Ritterbush Fund, and the MIT Center for Precision Cancer Medicine.
Grant: -
FWCI
1.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords